Trial Profile
A retrospective study investigating the effect of alemtuzumab and relation of morbidity and age in patients who underwent renal transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 19 Aug 2015 New trial record